PMC5523231_01
PMC5523231_02
Symptom progression and related interventions during hospitalization.
CRIPE2017-4083785.001.jpg
PMC5523231_02_CRIPE2017-4083785.001.jpg
fig1
Patient had further decline in his initial days of hospitalization with episodic agitation, insomnia, psychomotor slowing with abnormal posturing, oral-lingual-facial dyskinesia, and progressive aphasia (Figure 1). On Hospital Day Three, he began empiric treatment with nine days of 10 mg/kg/day intravenous methylprednisolone and a five-day course of 400 mg/kg/day intravenous immunoglobulin given high clinical suspicion for autoimmune encephalitis based on his progressive multistage illness and clinical features (Figure 1).
Initial electroencephalogram.
CRIPE2017-4083785.002.jpg
PMC5523231_02_CRIPE2017-4083785.002.jpg
fig2
The EEG was abnormal due to prolonged diffuse theta and delta admixture bilaterally but more prominent on the left suggestive of moderate diffuse cerebral encephalopathy (Figure 2).